drugset / Trial / NCT00006260

Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer

NCT00006260

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Drugs such as mesna may be effective in preventing some of the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of etoposide and ifosfamide given with mesna, and cisplatin in treating patients who have metastatic breast cancer.

Timeline

Start
1997-05
Primary completion
2005-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified Intravenous
Subject Etoposide Small molecule Intravenous
Subject Ifosfamide Small molecule Intravenous
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule Intravenous

Indications